David Michalovich
Research Subjects
David Michalovich has a total of 258 co-authors. Here are the top co-authors by number of shared publications:
- Edith M. Hessel
Refractory Respiratory Inflammation Discovery Performance Unit, GlaxoSmithKline, Stevenage, UK
5 shared publications Henry M. Sarau
GlaxoSmithKline plc
3 shared publications- Liam O Mahony
Department of Medicine, School of Microbiology APC Microbiome Ireland, University College Cork Cork Ireland
3 shared publications Shelagh Wilson
GlaxoSmithKline plc
3 shared publications- Sylwia Smolinska
Department of Clinical Immunology, Faculty of Medicine, Wroclaw Medical University, Parkowa 34, 51-616 Wroclaw, Poland
3 shared publications - Benoit Pugin
Laboratory of Food Biotechnology, Eidgenössische Technische Hochschule Zürich, 8092 Zürich, Switzerland
2 shared publications
Latest Publications
- Open Access
- 1 June 2023
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 61 (6) , 2201667
Genome-wide association study of chronic sputum production implicates loci involved in mucus production and infection
Background: Chronic sputum production impacts on quality of life and is a feature of many respiratory diseases. Identification of the genetic variants associated with chronic sputum production in a disease agnostic sample could improve understanding of its causes and identify new molecular targets for treatment.Methods: We conducted a genome-wide association study (GWAS) of chronic sputum production in UK Biobank. Signals meeting genome-wide significance (p−8) were investigated in additional independent studies, were fine-mapped and putative causal genes identified by gene expression analysis. GWASs of respiratory traits were interrogated to identify whether the signals were driven by existing respiratory disease among the cases and variants were further investigated for wider pleiotropic effects using phenome-wide association studies (PheWASs).Results: From a GWAS of 9714 cases and 48 471 controls, we identified six novel genome-wide significant signals for chronic sputum production including signals in the human leukocyte antigen (HLA) locus, chromosome 11 mucin locus (containingMUC2,MUC5ACandMUC5B) andFUT2locus. The four common variant associations were supported by independent studies with a combined sample size of up to 2203 cases and 17 627 controls. The mucin locus signal had previously been reported for association with moderate-to-severe asthma. The HLA signal was fine-mapped to an amino acid change of threonine to arginine (frequency 36.8%) in HLA-DRB1 (HLA-DRB1*03:147). The signal nearFUT2was associated with expression of several genes includingFUT2, for which the direction of effect was tissue dependent. Our PheWAS identified a wide range of associations including blood cell traits, liver biomarkers, infections, gastrointestinal and thyroid-associated diseases, and respiratory disease.Conclusions: Novel signals at theFUT2and mucin loci suggest that mucin fucosylation may be a driver of chronic sputum production even in the absence of diagnosed respiratory disease and provide genetic support for this pathway as a target for therapeutic intervention.
- 1 June 2023
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 61 (6) , 2201667
Open AccessGenome-wide association study of chronic sputum production implicates loci involved in mucus production and infection
Background: Chronic sputum production impacts on quality of life and is a feature of many respiratory diseases. Identification of the genetic variants associated with chronic sputum production in a disease agnostic sample could improve understanding of its causes and identify new molecular targets for treatment.Methods: We conducted a genome-wide association study (GWAS) of chronic sputum production in UK Biobank. Signals meeting genome-wide significance (p−8) were investigated in additional independent studies, were fine-mapped and putative causal genes identified by gene expression analysis. GWASs of respiratory traits were interrogated to identify whether the signals were driven by existing respiratory disease among the cases and variants were further investigated for wider pleiotropic effects using phenome-wide association studies (PheWASs).Results: From a GWAS of 9714 cases and 48 471 controls, we identified six novel genome-wide significant signals for chronic sputum production including signals in the human leukocyte antigen (HLA) locus, chromosome 11 mucin locus (containingMUC2,MUC5ACandMUC5B) andFUT2locus. The four common variant associations were supported by independent studies with a combined sample size of up to 2203 cases and 17 627 controls. The mucin locus signal had previously been reported for association with moderate-to-severe asthma. The HLA signal was fine-mapped to an amino acid change of threonine to arginine (frequency 36.8%) in HLA-DRB1 (HLA-DRB1*03:147). The signal nearFUT2was associated with expression of several genes includingFUT2, for which the direction of effect was tissue dependent. Our PheWAS identified a wide range of associations including blood cell traits, liver biomarkers, infections, gastrointestinal and thyroid-associated diseases, and respiratory disease.Conclusions: Novel signals at theFUT2and mucin loci suggest that mucin fucosylation may be a driver of chronic sputum production even in the absence of diagnosed respiratory disease and provide genetic support for this pathway as a target for therapeutic intervention.
- 14 February 2020
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 55 (5) , 1900950
Highly efficient genome editing in primary human bronchial epithelial cells differentiated at air–liquid interface
- 14 February 2020
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 55 (5) , 1900950
Highly efficient genome editing in primary human bronchial epithelial cells differentiated at air–liquid interface
- Top Cited PapersOpen Access
- 13 December 2019
- Published by Springer Nature in Nature Communications
- Vol. 10 (1) , 1-14
Obesity and disease severity magnify disturbed microbiome-immune interactions in asthma patients
In order to improve targeted therapeutic approaches for asthma patients, insights into the molecular mechanisms that differentially contribute to disease phenotypes, such as obese asthmatics or severe asthmatics, are required. Here we report immunological and microbiome alterations in obese asthmatics (n = 50, mean age = 45), non-obese asthmatics (n = 53, mean age = 40), obese non-asthmatics (n = 51, mean age = 44) and their healthy counterparts (n = 48, mean age = 39). Obesity is associated with elevated proinflammatory signatures, which are enhanced in the presence of asthma. Similarly, obesity or asthma induced changes in the composition of the microbiota, while an additive effect is observed in obese asthma patients. Asthma disease severity is negatively correlated with fecal Akkermansia muciniphila levels. Administration of A. muciniphila to murine models significantly reduces airway hyper-reactivity and airway inflammation. Changes in immunological processes and microbiota composition are accentuated in obese asthma patients due to the additive effects of both disease states, while A. muciniphila may play a non-redundant role in patients with a severe asthma phenotype.
- 13 December 2019
- Published by Springer Nature in Nature Communications
- Vol. 10 (1) , 1-14
Top Cited PapersOpen AccessObesity and disease severity magnify disturbed microbiome-immune interactions in asthma patients
In order to improve targeted therapeutic approaches for asthma patients, insights into the molecular mechanisms that differentially contribute to disease phenotypes, such as obese asthmatics or severe asthmatics, are required. Here we report immunological and microbiome alterations in obese asthmatics (n = 50, mean age = 45), non-obese asthmatics (n = 53, mean age = 40), obese non-asthmatics (n = 51, mean age = 44) and their healthy counterparts (n = 48, mean age = 39). Obesity is associated with elevated proinflammatory signatures, which are enhanced in the presence of asthma. Similarly, obesity or asthma induced changes in the composition of the microbiota, while an additive effect is observed in obese asthma patients. Asthma disease severity is negatively correlated with fecal Akkermansia muciniphila levels. Administration of A. muciniphila to murine models significantly reduces airway hyper-reactivity and airway inflammation. Changes in immunological processes and microbiota composition are accentuated in obese asthma patients due to the additive effects of both disease states, while A. muciniphila may play a non-redundant role in patients with a severe asthma phenotype.
- Open Access
- 27 February 2018
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 9, 369
Activated PI3 Kinase Delta Syndrome: From Genetics to Therapy
Activated PI3 kinase delta syndrome (APDS) is a primary immunodeficiency caused by dominant mutations that increase activity of phosphoinositide-3-kinase δ (PI3Kδ). APDS can be caused by mutations in the PIK3CD gene that encodes PI3Kδ catalytic subunit p110δ (APDS1) or mutations in the PIK3R1 gene that encodes regulatory subunit p85α (APDS2). APDS research advanced rapidly after the initial discovery in 2013. More than 200 APDS patients have been identified around the world. Multiple novel APDS mutations were reported and molecular mechanisms leading to PI3Kδ activation have been elucidated. The finding of APDS significantly increased our understanding of the role of PI3Kδ in the human immune system. Perhaps most importantly, discovery of the molecular basis of this primary immunodeficiency suggested that APDS patients, who previously received only non-specific therapy, could be treated by a novel class of drugs that inhibits PI3Kδ activity. This led to the ongoing clinical trials of selective PI3Kδ inhibitors in APDS patients. Overall, the APDS story provides an excellent example of translational research, beginning with patients who had an unknown disease cause and leading to a novel specific knowledge-based treatment.
- 27 February 2018
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 9, 369
Open AccessActivated PI3 Kinase Delta Syndrome: From Genetics to Therapy
Activated PI3 kinase delta syndrome (APDS) is a primary immunodeficiency caused by dominant mutations that increase activity of phosphoinositide-3-kinase δ (PI3Kδ). APDS can be caused by mutations in the PIK3CD gene that encodes PI3Kδ catalytic subunit p110δ (APDS1) or mutations in the PIK3R1 gene that encodes regulatory subunit p85α (APDS2). APDS research advanced rapidly after the initial discovery in 2013. More than 200 APDS patients have been identified around the world. Multiple novel APDS mutations were reported and molecular mechanisms leading to PI3Kδ activation have been elucidated. The finding of APDS significantly increased our understanding of the role of PI3Kδ in the human immune system. Perhaps most importantly, discovery of the molecular basis of this primary immunodeficiency suggested that APDS patients, who previously received only non-specific therapy, could be treated by a novel class of drugs that inhibits PI3Kδ activity. This led to the ongoing clinical trials of selective PI3Kδ inhibitors in APDS patients. Overall, the APDS story provides an excellent example of translational research, beginning with patients who had an unknown disease cause and leading to a novel specific knowledge-based treatment.
Altered fatty acid metabolism and reduced stearoyl‐coenzyme a desaturase activity in asthma
Background: Fatty acids and lipid mediator signaling play an important role in the pathogenesis of asthma, yet this area remains largely underexplored. The aims of this study were (i) to examine fatty acid levels and their metabolism in obese and nonobese asthma patients and (ii) to determine the functional effects of altered fatty acid metabolism in experimental models.Methods: Medium‐ and long‐chain fatty acid levels were quantified in serum from 161 human volunteers by LC/MS. Changes in stearoyl‐coenzyme A desaturase (SCD) expression and activity were evaluated in the ovalbumin (OVA) and house dust mite (HDM) murine models. Primary human bronchial epithelial cells from asthma patients and controls were evaluated for SCD expression and activity.Results: The serum desaturation index (an indirect measure of SCD) was significantly reduced in nonobese asthma patients and in the OVA murine model. SCD1 gene expression was significantly reduced within the lungs following OVA or HDM challenge. Inhibition of SCD in mice promoted airway hyper‐responsiveness. SCD1 expression was suppressed in bronchial epithelial cells from asthma patients. IL‐4 and IL‐13 reduced epithelial cell SCD1 expression. Inhibition of SCD reduced surfactant protein C expression and suppressed rhinovirus‐induced IP‐10 secretion, which was associated with increased viral titers.Conclusions: This is the first study to demonstrate decreased fatty acid desaturase activity in humans with asthma. Experimental models in mice and human epithelial cells suggest that inhibition of desaturase activity leads to airway hyper‐responsiveness and reduced antiviral defense. SCD may represent a new target for therapeutic intervention in asthma patients.
Altered fatty acid metabolism and reduced stearoyl‐coenzyme a desaturase activity in asthma
Background: Fatty acids and lipid mediator signaling play an important role in the pathogenesis of asthma, yet this area remains largely underexplored. The aims of this study were (i) to examine fatty acid levels and their metabolism in obese and nonobese asthma patients and (ii) to determine the functional effects of altered fatty acid metabolism in experimental models.Methods: Medium‐ and long‐chain fatty acid levels were quantified in serum from 161 human volunteers by LC/MS. Changes in stearoyl‐coenzyme A desaturase (SCD) expression and activity were evaluated in the ovalbumin (OVA) and house dust mite (HDM) murine models. Primary human bronchial epithelial cells from asthma patients and controls were evaluated for SCD expression and activity.Results: The serum desaturation index (an indirect measure of SCD) was significantly reduced in nonobese asthma patients and in the OVA murine model. SCD1 gene expression was significantly reduced within the lungs following OVA or HDM challenge. Inhibition of SCD in mice promoted airway hyper‐responsiveness. SCD1 expression was suppressed in bronchial epithelial cells from asthma patients. IL‐4 and IL‐13 reduced epithelial cell SCD1 expression. Inhibition of SCD reduced surfactant protein C expression and suppressed rhinovirus‐induced IP‐10 secretion, which was associated with increased viral titers.Conclusions: This is the first study to demonstrate decreased fatty acid desaturase activity in humans with asthma. Experimental models in mice and human epithelial cells suggest that inhibition of desaturase activity leads to airway hyper‐responsiveness and reduced antiviral defense. SCD may represent a new target for therapeutic intervention in asthma patients.
- 1 November 2016
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 138 (5) , 1491-1494.e7
Histamine-secreting microbes are increased in the gut of adult asthma patients
- 1 November 2016
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 138 (5) , 1491-1494.e7
Histamine-secreting microbes are increased in the gut of adult asthma patients
- 31 January 2014
- Published by Springer Nature in Nature Reviews Drug Discovery
- Vol. 13 (2) , 83-84
Precompetitive activity to address the biological data needs of drug discovery
- 31 January 2014
- Published by Springer Nature in Nature Reviews Drug Discovery
- Vol. 13 (2) , 83-84
Precompetitive activity to address the biological data needs of drug discovery
- Top Cited PapersOpen Access
- 23 September 2011
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 40 (D1) , D1100-D1107
ChEMBL: a large-scale bioactivity database for drug discovery
ChEMBL is an Open Data database containing binding, functional and ADMET information for a large number of drug-like bioactive compounds. These data are manually abstracted from the primary published literature on a regular basis, then further curated and standardized to maximize their quality and utility across a wide range of chemical biology and drug-discovery research problems. Currently, the database contains 5.4 million bioactivity measurements for more than 1 million compounds and 5200 protein targets. Access is available through a web-based interface, data downloads and web services at: https://www.ebi.ac.uk/chembldb.
- 23 September 2011
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 40 (D1) , D1100-D1107
Top Cited PapersOpen AccessChEMBL: a large-scale bioactivity database for drug discovery
ChEMBL is an Open Data database containing binding, functional and ADMET information for a large number of drug-like bioactive compounds. These data are manually abstracted from the primary published literature on a regular basis, then further curated and standardized to maximize their quality and utility across a wide range of chemical biology and drug-discovery research problems. Currently, the database contains 5.4 million bioactivity measurements for more than 1 million compounds and 5200 protein targets. Access is available through a web-based interface, data downloads and web services at: https://www.ebi.ac.uk/chembldb.
Gene profiling and bioinformatic analysis of Schwann cell embryonic development and myelination
To elucidate the molecular mechanisms involved in Schwann cell development, we profiled gene expression in the developing and injured rat sciatic nerve. The genes that showed significant changes in expression in developing and dedifferentiated nerve were validated with RT‐PCR, in situ hybridisation, Western blot and immunofluorescence. A comprehensive approach to annotating micro‐array probes and their associated transcripts was performed using Biopendium™, a database of sequence and structural annotation. This approach significantly increased the number of genes for which a functional insight could be found. The analysis implicates agrin and two members of the collapsin response‐mediated protein (CRMP) family in the switch from precursors to Schwann cells, and synuclein‐1 and αB‐crystallin in peripheral nerve myelination. We also identified a group of genes typically related to chondrogenesis and cartilage/bone development, including type II collagen, that were expressed in a manner similar to that of myelin‐associated genes. The comprehensive function annotation also identified, among the genes regulated during nerve development or after nerve injury, proteins belonging to high‐interest families, such as cytokines and kinases, and should therefore provide a uniquely valuable resource for future research.
Gene profiling and bioinformatic analysis of Schwann cell embryonic development and myelination
To elucidate the molecular mechanisms involved in Schwann cell development, we profiled gene expression in the developing and injured rat sciatic nerve. The genes that showed significant changes in expression in developing and dedifferentiated nerve were validated with RT‐PCR, in situ hybridisation, Western blot and immunofluorescence. A comprehensive approach to annotating micro‐array probes and their associated transcripts was performed using Biopendium™, a database of sequence and structural annotation. This approach significantly increased the number of genes for which a functional insight could be found. The analysis implicates agrin and two members of the collapsin response‐mediated protein (CRMP) family in the switch from precursors to Schwann cells, and synuclein‐1 and αB‐crystallin in peripheral nerve myelination. We also identified a group of genes typically related to chondrogenesis and cartilage/bone development, including type II collagen, that were expressed in a manner similar to that of myelin‐associated genes. The comprehensive function annotation also identified, among the genes regulated during nerve development or after nerve injury, proteins belonging to high‐interest families, such as cytokines and kinases, and should therefore provide a uniquely valuable resource for future research.
- Open Access
- 1 October 2005
- Published by Bioscientifica in Journal of Endocrinology
- Vol. 187 (1) , 89-101
Regulated expression of putative membrane progestin receptor homologues in human endometrium and gestational tissues
Rapid non-genomic actions of progesterone are implicated in many aspects of female reproduction. Recently, three human homologues of the fish membrane progestin receptor (mPR) have been identified. We combined bioinformatic analysis with expression profiling to define further the role of these mPRs in human reproductive tissues. Sequence analysis confirmed that the mPRs belong to a larger, highly conserved family of proteins, termed ‘progestin and adiponectin receptors’ (PAQRs). A comparison of the expression of mPR transcripts with that of two related PAQR family members, PAQRIII and PAQRIX, in cycling endometrium and pregnancy tissues revealed markedly divergent expression levels and profiles. For instance, endometrial expression of mPRα and γ and PAQRIX was cycle-dependent whereas the onset of parturition was associated with a marked reduction in myometrial mPRα and β transcripts. Interestingly, mPRα and PAQRIX were most highly expressed in the placenta, and the tissue expression levels of both genes correlated inversely with that of the nuclear PR. Phylogenetic analysis demonstrated that PAQRIX belongs to the mPR subgroup of proteins. We also validated a polyclonal antibody raised against the carboxy-terminus of human mPRα. Immunohistochemical analysis demonstrated more intense immunoreactivity in placental syncytiotrophoblasts than in endometrial glands or stroma. The data suggest important functional roles for mPRα, and possibly PAQRIX, in specific reproductive tissues, particularly those that express low levels of nuclear PR.
- 1 October 2005
- Published by Bioscientifica in Journal of Endocrinology
- Vol. 187 (1) , 89-101
Open AccessRegulated expression of putative membrane progestin receptor homologues in human endometrium and gestational tissues
Rapid non-genomic actions of progesterone are implicated in many aspects of female reproduction. Recently, three human homologues of the fish membrane progestin receptor (mPR) have been identified. We combined bioinformatic analysis with expression profiling to define further the role of these mPRs in human reproductive tissues. Sequence analysis confirmed that the mPRs belong to a larger, highly conserved family of proteins, termed ‘progestin and adiponectin receptors’ (PAQRs). A comparison of the expression of mPR transcripts with that of two related PAQR family members, PAQRIII and PAQRIX, in cycling endometrium and pregnancy tissues revealed markedly divergent expression levels and profiles. For instance, endometrial expression of mPRα and γ and PAQRIX was cycle-dependent whereas the onset of parturition was associated with a marked reduction in myometrial mPRα and β transcripts. Interestingly, mPRα and PAQRIX were most highly expressed in the placenta, and the tissue expression levels of both genes correlated inversely with that of the nuclear PR. Phylogenetic analysis demonstrated that PAQRIX belongs to the mPR subgroup of proteins. We also validated a polyclonal antibody raised against the carboxy-terminus of human mPRα. Immunohistochemical analysis demonstrated more intense immunoreactivity in placental syncytiotrophoblasts than in endometrial glands or stroma. The data suggest important functional roles for mPRα, and possibly PAQRIX, in specific reproductive tissues, particularly those that express low levels of nuclear PR.